very disappointing announcement, but not unexpected for OHD which was always a long shot requiring much more work before it's close to being validated commercially - plus the admission that field trials at this time are out of the question. Problem is, without field trials it won't get commercial acceptance. Years away from any OHD success.
as I've said in earlier posts the only short term chance of sp improvement was Morobasi but the way this company delivers that's probably a lifetime away as well...
time for a serious reassessment of whether it's worth hanging around GPP....
Add to My Watchlist
What is My Watchlist?
